Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

Clinical trial NCT02342145 · COMPLETED

Trial details

NCT number: NCT02342145
Sponsor: Zhongming Zhang
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Beta-Thalassemia Major Graft-versus-host Disease (GVHD)

Start date: 2015-04-01
Primary completion: 2022-08-20
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.